The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats

Pil W. Huh, Ludmila Belayev, Weizhao Zhao, Raul Busto, Isabel Saul, Myron Ginsberg

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

We have shown that high-concentration albumin therapy is markedly neuroprotective in focal cerebral ischemia. The present study was conducted to ascertain the degree to which hemodynamic alterations are responsible for this therapeutic effect. Normothermic, physiologically regulated male Sprague-Dawley rats received a 2-h period of middle cerebral artery occlusion (MCAo) by insertion of an intraluminal suture coated with poly-L-lysine. Albumin (25% human serum albumin solution) or vehicle (0.9% sodium chloride) was administered intravenously at a dose of 1% of body weight immediately after suture withdrawal following 2-h MCAo. Local cerebral blood flow (LCBF) was measured autoradiographically with 14C - iodoantipyrine after 1 h of recirculation. Novel image-processing methods were used to compare average LCBF data sets against previously obtained infarction-frequency data on a pixel-by-pixel basis. Albumin therapy reduced mean hematocrit by 42% but produced no other systemic alterations. Pixel-based histopathological analysis revealed large, consistent cortical and subcortical infarcts in saline-treated rats with MCAo; albumin therapy reduced mean cortical infarct volume by 85%. Within regions showing albumin-associated neuroprotection, numbers of pixels having LCBF in the upper ischemic-core flow range (0.12- 0.24 ml g-1 min-1) were reduced by 8.6-fold by albumin therapy when compared to saline-treated rats; and numbers of pixels with LCBF in the lower penumbral flow range (0.24-0.36 ml g-1 min-1) were reduced by 3.1-fold in albumin-treated rats (p = 0.04 by repeated-measures analysis of variance). Analysis of the [albumin-saline] 3-dimensional difference-image data set revealed a circumferential zone of statistically significant albumin- associated LCBF increase within the posterior portion of the ischemic hemisphere, surrounding the core-region of prior ischemia. Thus, high- concentration albumin therapy improves local perfusion to regions of critical LCBF reduction. The spatial extent of this LCBF effect, however, appears too small to account fully for the marked neuroprotective efficacy of this therapy. We suggest that other, non-hemodynamic mechanisms may also be contributory.

Original languageEnglish
Pages (from-to)105-113
Number of pages9
JournalBrain Research
Volume804
Issue number1
DOIs
StatePublished - Aug 31 1998

Fingerprint

Cerebrovascular Circulation
Transient Ischemic Attack
Albumins
Perfusion
Middle Cerebral Artery Infarction
Therapeutics
Sutures
Therapeutic Uses
Brain Ischemia
Hematocrit
Sodium Chloride
Serum Albumin
Infarction
Lysine
Sprague Dawley Rats
Analysis of Variance
Ischemia
Hemodynamics
Body Weight

Keywords

  • Autoradiography
  • Cerebral blood flow
  • Image-processing
  • Middle cerebral artery occlusion
  • Neuroprotection

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats. / Huh, Pil W.; Belayev, Ludmila; Zhao, Weizhao; Busto, Raul; Saul, Isabel; Ginsberg, Myron.

In: Brain Research, Vol. 804, No. 1, 31.08.1998, p. 105-113.

Research output: Contribution to journalArticle

@article{e16ff800dc0f4df8bfa1db17a466f962,
title = "The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats",
abstract = "We have shown that high-concentration albumin therapy is markedly neuroprotective in focal cerebral ischemia. The present study was conducted to ascertain the degree to which hemodynamic alterations are responsible for this therapeutic effect. Normothermic, physiologically regulated male Sprague-Dawley rats received a 2-h period of middle cerebral artery occlusion (MCAo) by insertion of an intraluminal suture coated with poly-L-lysine. Albumin (25{\%} human serum albumin solution) or vehicle (0.9{\%} sodium chloride) was administered intravenously at a dose of 1{\%} of body weight immediately after suture withdrawal following 2-h MCAo. Local cerebral blood flow (LCBF) was measured autoradiographically with 14C - iodoantipyrine after 1 h of recirculation. Novel image-processing methods were used to compare average LCBF data sets against previously obtained infarction-frequency data on a pixel-by-pixel basis. Albumin therapy reduced mean hematocrit by 42{\%} but produced no other systemic alterations. Pixel-based histopathological analysis revealed large, consistent cortical and subcortical infarcts in saline-treated rats with MCAo; albumin therapy reduced mean cortical infarct volume by 85{\%}. Within regions showing albumin-associated neuroprotection, numbers of pixels having LCBF in the upper ischemic-core flow range (0.12- 0.24 ml g-1 min-1) were reduced by 8.6-fold by albumin therapy when compared to saline-treated rats; and numbers of pixels with LCBF in the lower penumbral flow range (0.24-0.36 ml g-1 min-1) were reduced by 3.1-fold in albumin-treated rats (p = 0.04 by repeated-measures analysis of variance). Analysis of the [albumin-saline] 3-dimensional difference-image data set revealed a circumferential zone of statistically significant albumin- associated LCBF increase within the posterior portion of the ischemic hemisphere, surrounding the core-region of prior ischemia. Thus, high- concentration albumin therapy improves local perfusion to regions of critical LCBF reduction. The spatial extent of this LCBF effect, however, appears too small to account fully for the marked neuroprotective efficacy of this therapy. We suggest that other, non-hemodynamic mechanisms may also be contributory.",
keywords = "Autoradiography, Cerebral blood flow, Image-processing, Middle cerebral artery occlusion, Neuroprotection",
author = "Huh, {Pil W.} and Ludmila Belayev and Weizhao Zhao and Raul Busto and Isabel Saul and Myron Ginsberg",
year = "1998",
month = "8",
day = "31",
doi = "10.1016/S0006-8993(98)00674-X",
language = "English",
volume = "804",
pages = "105--113",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats

AU - Huh, Pil W.

AU - Belayev, Ludmila

AU - Zhao, Weizhao

AU - Busto, Raul

AU - Saul, Isabel

AU - Ginsberg, Myron

PY - 1998/8/31

Y1 - 1998/8/31

N2 - We have shown that high-concentration albumin therapy is markedly neuroprotective in focal cerebral ischemia. The present study was conducted to ascertain the degree to which hemodynamic alterations are responsible for this therapeutic effect. Normothermic, physiologically regulated male Sprague-Dawley rats received a 2-h period of middle cerebral artery occlusion (MCAo) by insertion of an intraluminal suture coated with poly-L-lysine. Albumin (25% human serum albumin solution) or vehicle (0.9% sodium chloride) was administered intravenously at a dose of 1% of body weight immediately after suture withdrawal following 2-h MCAo. Local cerebral blood flow (LCBF) was measured autoradiographically with 14C - iodoantipyrine after 1 h of recirculation. Novel image-processing methods were used to compare average LCBF data sets against previously obtained infarction-frequency data on a pixel-by-pixel basis. Albumin therapy reduced mean hematocrit by 42% but produced no other systemic alterations. Pixel-based histopathological analysis revealed large, consistent cortical and subcortical infarcts in saline-treated rats with MCAo; albumin therapy reduced mean cortical infarct volume by 85%. Within regions showing albumin-associated neuroprotection, numbers of pixels having LCBF in the upper ischemic-core flow range (0.12- 0.24 ml g-1 min-1) were reduced by 8.6-fold by albumin therapy when compared to saline-treated rats; and numbers of pixels with LCBF in the lower penumbral flow range (0.24-0.36 ml g-1 min-1) were reduced by 3.1-fold in albumin-treated rats (p = 0.04 by repeated-measures analysis of variance). Analysis of the [albumin-saline] 3-dimensional difference-image data set revealed a circumferential zone of statistically significant albumin- associated LCBF increase within the posterior portion of the ischemic hemisphere, surrounding the core-region of prior ischemia. Thus, high- concentration albumin therapy improves local perfusion to regions of critical LCBF reduction. The spatial extent of this LCBF effect, however, appears too small to account fully for the marked neuroprotective efficacy of this therapy. We suggest that other, non-hemodynamic mechanisms may also be contributory.

AB - We have shown that high-concentration albumin therapy is markedly neuroprotective in focal cerebral ischemia. The present study was conducted to ascertain the degree to which hemodynamic alterations are responsible for this therapeutic effect. Normothermic, physiologically regulated male Sprague-Dawley rats received a 2-h period of middle cerebral artery occlusion (MCAo) by insertion of an intraluminal suture coated with poly-L-lysine. Albumin (25% human serum albumin solution) or vehicle (0.9% sodium chloride) was administered intravenously at a dose of 1% of body weight immediately after suture withdrawal following 2-h MCAo. Local cerebral blood flow (LCBF) was measured autoradiographically with 14C - iodoantipyrine after 1 h of recirculation. Novel image-processing methods were used to compare average LCBF data sets against previously obtained infarction-frequency data on a pixel-by-pixel basis. Albumin therapy reduced mean hematocrit by 42% but produced no other systemic alterations. Pixel-based histopathological analysis revealed large, consistent cortical and subcortical infarcts in saline-treated rats with MCAo; albumin therapy reduced mean cortical infarct volume by 85%. Within regions showing albumin-associated neuroprotection, numbers of pixels having LCBF in the upper ischemic-core flow range (0.12- 0.24 ml g-1 min-1) were reduced by 8.6-fold by albumin therapy when compared to saline-treated rats; and numbers of pixels with LCBF in the lower penumbral flow range (0.24-0.36 ml g-1 min-1) were reduced by 3.1-fold in albumin-treated rats (p = 0.04 by repeated-measures analysis of variance). Analysis of the [albumin-saline] 3-dimensional difference-image data set revealed a circumferential zone of statistically significant albumin- associated LCBF increase within the posterior portion of the ischemic hemisphere, surrounding the core-region of prior ischemia. Thus, high- concentration albumin therapy improves local perfusion to regions of critical LCBF reduction. The spatial extent of this LCBF effect, however, appears too small to account fully for the marked neuroprotective efficacy of this therapy. We suggest that other, non-hemodynamic mechanisms may also be contributory.

KW - Autoradiography

KW - Cerebral blood flow

KW - Image-processing

KW - Middle cerebral artery occlusion

KW - Neuroprotection

UR - http://www.scopus.com/inward/record.url?scp=0032584965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032584965&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(98)00674-X

DO - 10.1016/S0006-8993(98)00674-X

M3 - Article

C2 - 9729310

AN - SCOPUS:0032584965

VL - 804

SP - 105

EP - 113

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -